Discovery through Partnership | Excellence through Quality
| Product Name | Retinoic acid |
| Description |
Retinoid RAR agonist |
| Field of Use | Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only. |
Properties
| Solubility | Soluble to 50 mM in ethanol and 25 mM in DMSO |
| Appearance | Yellow solid |
| Safety Phrases |
Classification: Toxic. May be harmful or fatal is inhaled, swallowed or absorbed through skin. Safety Phrases: S22 - Do not breathe dust S24/25 - Avoid contact with skin and eyes S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection Risk Phrases: R20/21/22 - Harmful by inhilation, in contact with skin and if swallowed R40 - Limited evidence of a carcinogenic effect R46 - May cause heritable genetic damage R62 - Possible risk of impaired fertility Hazard Phrases: H302-H411 Precautionary Phrases: P273 |
| Cite This Product | Retinoic acid (StressMarq Biosciences, Canada, Cat # SIH-258) |
Biological Description
| Alternative Names | Tretinoin, ATRA |
| Scientific Background | Retinoic acid is a metabolite of Vitamin A that mediates the functions of vitamin A required for growth and development. It is generated in a specific region of the embryo during early embryonic development (1). |
| References | 1. Duester G. (2008) Cell. 134: 921-931. |
Product Images
Chemical structure of Retinoic acid (SIH-258), a Retinoid RAR agonist. CAS #: 302-79-4. Molecular Formula: C20H28O2. Molecular Weight: 300.44 g/mol.
Powered by Bioz
StressMarq Biosciences :
Based on validation through cited publications.